Hobart Healthcare is a holding company of an international portfolio of medical device companies that includes over 200 scientists, engineers, regulatory and business experts. Through our world renowned adivsory board we accelerate ideas, develop and commercialize technologies targeting top medical markets with significant unmet needs and large exit potentials including cardiology, diabetes, oncology, neurology, rehabilitation and blood banking. Our clinical expertise and extensive regulatory and market knowledge spans across Europe, the US and Asia. Hobart’s founder, Professor Shlomo Ben-Haim, is a medical device entrepreneur. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics at both Harvard University and the Technion – Israel Institute of Technology, and has a an impressive record of co-founding companies and maximizing their value. Some of his notable exits include the sales of Biosense to Johnson & Johnson and X-Technologies to Guidant.